$CMCMNeutralMed

Cheetah Mobile Announces First Quarter 2026 Unaudited Consolidated Financial Results

Cheetah Mobile reported unaudited Q1 2026 results for the quarter ended March 31, 2026. Total revenue was RMB259.0 million (US$37.5 million). Robotics and others rose 175.9% YoY to RMB51.2 million (19.8% of revenue). Net loss attributable to shareholders was RMB17.5 million (US$2.5 million), versus RMB33.4 million a year earlier. Cash and cash equivalents were RMB1,280.6 million (US$185.6 million).

8/10
8/10
Med
Neutral
today’s Q1 2026 earnings release (quarter ended Mar 31, 2026)
Improving robotics/AI infrastructure growth partially offsets ongoing advertising weakness; overall sentiment likely neutral to slightly positive for the AI/robotics narrative.

Segment mix is improving (robotics growth, adjusted loss narrowing) but core internet/advertising remains pressured, keeping profitability risk elevated.

Cheetah Mobile reported Q1 2026 results showing robotics and others revenue up 175.9% YoY to RMB51.2M and narrowed adjusted operating loss.

Near-term bias likely mixed: upside from robotics/AI infrastructure growth and cash balance, offset by continued advertising-driven revenue declines.

Background

Cheetah Mobile (CMCM) released unaudited Q1 2026 consolidated financial results and introduced separate segment reporting for robotics starting this quarter.

Why it matters

Key trading focus is the divergence between fast-growing robotics/AI infrastructure revenue and weakening advertising-linked internet/enterprise services, alongside loss narrowing and cash runway.

Market relevance

Robotics/AI infrastructure momentum improved materially, but consolidated revenue was flat and advertising policy shifts continued to weigh on internet and enterprise services profitability.

Market effects

Provides read-through on demand for AI agent infrastructure/cloud services and enterprise adoption, while highlighting continued weakness in online advertising monetization.

China-based AI/robotics software name; results may influence sentiment toward China AI application vendors with enterprise/cloud exposure.

US-listed China tech earnings can affect broader risk appetite for small/mid-cap AI software and cross-border capital flows.

Alternative perspectives

Robotics growth may be early-stage and not yet translating into sustained consolidated profitability, given total revenue flat YoY and continued advertising declines.

The company began separately reporting robotics from Q1 2026, so investors should watch for comparability effects and whether adjusted operating loss improvement persists in subsequent quarters.

Key entities

  • Cheetah Mobile Inc.

    Reported Q1 2026 unaudited results; robotics and others revenue surged while advertising-driven segments declined.

  • EasyClaw

    AI agent platform for enterprise productivity scenarios referenced in management commentary.

  • Fu Sheng

    CEO commentary on AI/robotics strategy execution and narrowing adjusted operating loss.

  • Thomas Ren

    CFO explanation of new robotics segment reporting and cash position.

Related articles

$AZNHighAI 8/10

AstraZeneca Plunges After New Heart Disease Drug Fails Trial

AstraZeneca said its heart disease drug Wainua failed to beat placebo in a clinical trial for transthyretin-mediated amyloid cardiomyopathy (ATTR-CM), according to AstraZeneca and Ionis Pharmaceuticals. AstraZeneca shares fell up to 10.6% in London and 5.7% on the NYSE. Rival ATTR-CM drug makers Pfizer, BridgeBio, and Alnylam initially moved higher or lower.

$WDFCMedAI 8/10

WD-40 Q3 Earnings Call Highlights

WD-40 Company (NASDAQ:WDFC) reported Q3 gross margin of 56.6% and non-GAAP net income of $31.5 million, with non-GAAP EPS of $2.33. EMEA sales rose 17% to $66.6 million and Asia-Pacific sales rose 24% to $27.3 million. FY2026 constant-currency net sales guidance is $652 million to $667 million. The board authorized a $100 million share repurchase program.

$RXSTMedAI 8/10

RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook

RxSight (NASDAQ:RXST) reported Q2 sales of 11 Light Delivery Devices (LDDs) and one LDD rental, lowering sales 20% and leaving an installed base of 1,166 units. Cash, cash equivalents and short-term investments were about $209M. It revised 2026 revenue to $140M-$160M, including $110M-$120M RxSight sales and $30M-$40M Alcon collaboration revenue, and raised gross margin outlook to 73%-75%.

$WDFCHighAI 9/10

Why WD-40 Stock Popped Today

WD-40 (WDFC) shares rose after the company reported fiscal 2026 Q3 net sales up 24% to $195 million and adjusted EPS of $2.33, above the $1.56 estimate. Operating income increased 47% to $40.3 million. WD-40 raised full-year guidance to net sales of $675-$690 million and adjusted EPS of $6.05-$6.35.